Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
SCLX, SCLXW | Scilex Holding Co | Director | $23.7K | +$19K | +400% | Oct 17, 2024 |
CASI | CASI Pharmaceuticals, Inc (DE) | Director | May 25, 2022 | |||
SRNE | Sorrento Therapeutics, Inc. | Director | Aug 30, 2021 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|